07.06.2016 | External Webinar: A new analysis capability to improve assessment of cardiac liability in high throughput electrophysiology

   SyncroPatch 384PE (a predecessor model of SyncroPatch 384i)

AstraZeneca has implemented the Nanion SyncroPatch 384PE electrophysiology platform. This webinar will show how AstraZeneca and Genedata developed a processing and analysis pipeline for the complex data, reading binary raw data directly from the instrument into Genedata Screener.
Organisation: Genedata AG.

2017 - HTS in Cardiac Safety

   CardioExcyte 96 presentation (slide deck)      (4.0 MB)